SANTO Company is a member of Polpharma international pharmaceutical group that is actively operating markets in Central and Eastern Europe, Caucasus and Central Asia.
The Company has been developed, produced and supplied to Kazakhstan and Central Asia affordable high quality medicine products. The Company’s production capacities enable it to produce annually 1 billion 283 million tablets, capsules and granules; 294 mln ampoules; 6 mln infusions; 40 mln vials of antibiotic powders (cephalosporins); 13 mln vials of antibiotics powders (penem/mycin); 4,5 mln vials of liquid oral medicine products.
Nowadays the Company implements the largest investment project on modernization of existing and construction new pharmaceutical facilities in compliance with GMP international standards, with investment volume of about USD 100mln.
The company possesses certifications of compliance with the international standard of Good Manufacturing Practice (GMP) for its manufacturing site for the production of injectable solutions and infusions, for the manufacturing site for the production of solid oral medicines, for its production line of infusion solutions and on the production site for aseptic filling of antibiotic powders. The certificate for compliance with the standard of the good distribution practice (GDP) of the company’s pharmaceutical warehouse.
The Company exports its products to six countries: Russia, Ukraine, Kyrgyzstan, Mongolia, Turkmenistan, and fulfills requirements of the domestic market.